Movement Alert|DexCom Falls 4.04% in Regular Trading, Executive Share Sale Disclosure Pressures Sentiment

Market Focus11-20 03:21

On November 20, DexCom fell 4.04% in Regular Trading, trading near $79.225 per share, with turnover of $149 million.

The clearest recent catalyst was a disclosed insider transaction: the company reported that Executive Vice President and Chief Legal Compliance Officer Michael Jon Brown sold 1,700 common shares on November 16 at $83.46 per share, for proceeds of about $141,882.

The filing showed Brown still directly held 95,034 shares after the sale. While DexCom previously reported third-quarter results above expectations, including adjusted EPS of $0.73 on revenue of $1.344 billion and raised full-year revenue guidance to $5.20 billion-$5.25 billion, the latest trading appears more immediately tied to short-term pressure from the executive sale disclosure rather than operating fundamentals.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment